Meridian Bioscience - 26 Year Stock Price History | VIVO

Historical daily share price chart and data for Meridian Bioscience since 1992 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Meridian Bioscience as of October 22, 2018 is 15.59.
Meridian Bioscience Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 14.9105 14.0392 16.6612 13.5648 15.5900 14.22%
2017 13.7435 16.7826 16.7826 11.5880 13.6492 -17.98%
2016 17.5956 17.5820 19.4450 14.7779 16.6416 -9.96%
2015 16.4492 14.1166 18.9151 14.1166 18.4827 30.29%
2014 16.8975 21.6019 22.5368 13.7202 14.1856 -35.37%
2013 18.5811 16.7515 22.0073 15.8154 21.9494 34.33%
2012 14.8924 14.6261 16.5659 12.9021 16.3399 13.08%
2011 15.8099 17.5013 20.5550 11.3111 14.4497 -15.73%
2010 14.9075 15.4368 17.9159 11.8580 17.1460 11.59%
2009 14.9950 18.0339 18.4118 10.7216 15.3655 -12.49%
2008 19.3109 20.1251 24.3419 13.3982 17.5582 -13.54%
2007 16.0158 10.9485 22.9282 10.8822 20.3073 87.52%
2006 10.3505 9.5473 11.9854 8.5693 10.8293 24.18%
2005 6.4804 5.0035 9.8738 3.8792 8.7203 76.37%
2004 3.3916 2.8539 5.2260 2.7269 4.9443 73.74%
2003 2.5075 1.8348 3.1265 1.7957 2.8458 57.81%
2002 1.6607 1.5700 1.9694 1.2661 1.8033 19.19%
2001 1.1559 1.1919 1.6529 0.5575 1.5130 28.54%
2000 1.7145 1.6663 2.5360 1.1323 1.1771 -29.36%
1999 1.6397 1.5115 1.9552 1.3530 1.6663 10.24%
1998 2.0980 2.2445 3.2189 1.1110 1.5115 -31.86%
1997 2.1866 2.6808 2.9231 1.2373 2.2183 -20.43%
1996 2.4903 2.3771 3.2581 1.8898 2.7880 17.29%
1995 1.5649 0.9687 2.4827 0.9687 2.3771 145.39%
1994 1.1370 1.1932 1.5001 0.8995 0.9687 -18.81%
1993 1.3043 1.2149 1.5899 1.0461 1.1932 -1.79%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.661B $0.201B
Meridian Bioscience, Inc. is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers. Its products provide accuracy, simplicity and speed for the early diagnosis and treatment of common medical conditions, such as C. difficile, H. pylori, foodborne diseases and respiratory infections. In addition, the company develops and manufactures a variety of biological and non-biological materials used in proficiency testing programs. Meridian diagnostic products are used outside of the human body and require little or no special equipment. Meridian Bioscience designs their products to enhance the well-being of the patient-while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal infections, serology, parasitology and fungal disease diagnosis.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.435B 19.38
Abbott Laboratories (ABT) United States $120.206B 24.38
Stryker (SYK) United States $62.741B 24.24
Boston Scientific (BSX) United States $50.643B 26.34
Baxter (BAX) United States $36.875B 25.10
Zimmer Biomet Holdings (ZBH) United States $25.257B 16.23
ResMed (RMD) United States $14.644B 29.07
Smith & Nephew SNATS (SNN) United Kingdom $14.612B 0.00
Perrigo (PRGO) Ireland $9.748B 13.83
Canopy Growth (CGC) Canada $9.572B 0.00
Bio-Rad Laboratories (BIO) United States $8.308B 53.35
Hill-Rom Holdings (HRC) United States $5.726B 19.42
Haemonetics (HAE) United States $5.555B 50.69
ICU Medical (ICUI) United States $5.444B 36.89
Insulet (PODD) United States $5.198B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.212B 0.00
Hutchison China MediTech (HCM) China $3.983B 0.00
Agios Pharmaceuticals (AGIO) United States $3.643B 0.00
Neogen (NEOG) United States $3.276B 49.61
NuVasive (NUVA) United States $3.270B 31.02
National Vision Holdings (EYE) United States $3.195B 70.55
Quidel (QDEL) United States $2.516B 51.55
NxStage Medical (NXTM) United States $1.836B 0.00
Phibro Animal Health (PAHC) United States $1.796B 25.58
Cardiovascular Systems (CSII) United States $1.258B 724.80
AtriCure (ATRC) United States $1.059B 0.00
VAREX IMAGING (VREX) United States $0.987B 16.12
Owens & Minor (OMI) United States $0.914B 9.77
OraSure Technologies (OSUR) United States $0.909B 59.44
Cerus (CERS) United States $0.879B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.875B 25.83
PetIQ (PETQ) United States $0.860B 28.12
Surmodics (SRDX) United States $0.853B 103.08
MacroGenics (MGNX) United States $0.766B 0.00
Omeros (OMER) United States $0.749B 0.00
Insys Therapeutics (INSY) United States $0.607B 0.00
LeMaitre Vascular (LMAT) United States $0.542B 26.98
Lantheus Holdings (LNTH) United States $0.510B 15.85
NanoString Technologies (NSTG) United States $0.452B 0.00
TG Therapeutics (TGTX) United States $0.423B 0.00
Quanterix (QTRX) United States $0.405B 0.00
Evolus (EOLS) United States $0.359B 0.00
Cytosorbents (CTSO) United States $0.327B 0.00
Utah Medical Products (UTMD) United States $0.322B 20.76
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.295B 0.00
Surface Oncology (SURF) United States $0.230B 0.00
Rockwell Medical (RMTI) United States $0.221B 0.00
BioLife Solutions (BLFS) United States $0.209B 0.00
Chimerix (CMRX) United States $0.170B 0.00
Bovie Medical (BVX) United States $0.168B 0.00
Fonar (FONR) United States $0.146B 7.21
Chembio Diagnostics (CEMI) United States $0.140B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.136B 0.00
United-Guardian (UG) United States $0.079B 17.33
Imprimis Pharmaceuticals (IMMY) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.073B 0.00
Female Health (VERU) United States $0.073B 0.00
InfuSystems Holdings (INFU) United States $0.062B 0.00
Trinity Biotech (TRIB) Ireland $0.061B 18.19
Neurotrope (NTRP) United States $0.055B 0.00
CAS Medical Systems (CASM) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.045B 0.00
Akers Biosciences Inc (AKER) United States $0.035B 0.00
Valeritas Holdings (VLRX) United States $0.030B 0.00
Capricor Therapeutics (CAPR) United States $0.026B 0.00
Myomo (MYO) United States $0.022B 0.00
Senestech (SNES) United States $0.022B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.019B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00